Perspectives on cannabis as a substitute for opioid analgesics

被引:28
|
作者
Khan, Sara P. [1 ]
Pickens, Thomas A. [1 ]
Berlau, Daniel J. [1 ]
机构
[1] Regis Univ, Sch Pharm, Dept Pharmaceut Sci, 3333 Regis Blvd H-28, Denver, CO 80221 USA
关键词
analgesia; marijuana; mu-opioid receptor agonists; opioid-sparing effect; synthetic CB2 agonist; CROSS-SECTIONAL SURVEY; CANNOT TELL US; MEDICAL MARIJUANA; RECREATIONAL USERS; VAPORIZED CANNABIS; DRUG-INTERACTIONS; NEUROPATHIC PAIN; UNITED-STATES; THC; DELTA(9)-TETRAHYDROCANNABINOL;
D O I
10.2217/pmt-2018-0051
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
With the opioid epidemic reaching new heights in the USA, it has become critical to find suitable alternatives to opioids. Cannabis, an antinociceptive, is a strong contender to help patients reduce their opioid usage. A growing literature has been examining the complex effects cannabis has on pain relief and on opioid usage; whether it is a substitute for opioids or increases their use. This review explores the studies that compare cannabis-opioid interactions and presents some challenges of cannabis research and usage. The practical clinical pharmacology of cannabis as an analgesic, including the route of administration, safety and pharmacokinetics, are discussed to address the concerns, as well as possible solutions, of cannabis as a pain reliever.
引用
收藏
页码:191 / 203
页数:13
相关论文
共 50 条
  • [31] The Role of Cannabis Legalization in the Opioid Crisis
    Hill, Kevin P.
    Saxon, Andrew J.
    JAMA INTERNAL MEDICINE, 2018, 178 (05) : 679 - 680
  • [32] Hot Topic: Global Trends in the Use of Opioid Analgesics
    Erthal, Juliana
    Berterame, Stefano
    Clare, Philip
    Mattick, Richard P.
    CURRENT ADDICTION REPORTS, 2019, 6 (01) : 41 - 48
  • [33] Morphine with dextromethorphan: Conversion from other opioid analgesics
    Chevlen, E
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (01) : S42 - S49
  • [34] Opioid Analgesics for Sedation and Analgesia During Mechanical Ventilation
    Zeller, Brandy
    Giebe, Jeanne
    NEONATAL NETWORK, 2015, 34 (02): : 113 - 116
  • [35] Designing safer analgesics: a focus on μ-opioid receptor pathways
    Pergolizzi, Joseph V., Jr.
    LeQuang, Jo Ann
    Taylor, Robert, Jr.
    Ossipov, Michael H.
    Colucci, Daniel
    Raffa, Robert B.
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (10) : 965 - 972
  • [36] Prevalence of Cannabis Use and Cannabis Route of Administration among Massachusetts Adults in Buprenorphine Treatment for Opioid Use Disorder
    Streck, Joanna M.
    Regan, Susan
    Bearnot, Benjamin
    Gupta, Priya S.
    Kalkhoran, Sara
    Kalagher, Kelly M.
    Wakeman, Sarah
    Rigotti, Nancy A.
    SUBSTANCE USE & MISUSE, 2022, 57 (07) : 1104 - 1110
  • [37] Bivalent and bifunctional opioid receptor ligands as novel analgesics
    Rehrauer, Kyle J.
    Cunningham, Christopher W.
    PHARMACOLOGICAL RESEARCH, 2023, 197
  • [38] Opioid Analgesics and Adverse Outcomes among Hemodialysis Patients
    Ishida, Julie H.
    McCulloch, Charles E.
    Steinman, Michael A.
    Grimes, Barbara A.
    Johansen, Kirsten L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (05): : 746 - 753
  • [39] Maternal treatment with opioid analgesics and risk for birth defects
    Broussard, Cheryl S.
    Rasmussen, Sonja A.
    Reefhuis, Jennita
    Friedman, Jan M.
    Jann, Michael W.
    Riehle-Colarusso, Tiffany
    Honein, Margaret A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (04) : 314.e1 - 314.e11
  • [40] Hot Topic: Global Trends in the Use of Opioid Analgesics
    Juliana Erthal
    Stefano Berterame
    Philip Clare
    Richard P. Mattick
    Current Addiction Reports, 2019, 6 : 41 - 48